Product Benefits

• Dual-Ingredient Efficiency: Combines Sodium Valproate and Valproic Acid to achieve a more stable and effective concentration of the active medication in the bloodstream.

• Controlled-Release (CR) Technology: Specifically designed to release the medication slowly over time, reducing "peaks and troughs" in blood levels and minimizing the risk of side effects.

• Broad-Spectrum Anticonvulsant: Highly effective against a wide variety of seizure types, including absence (petit mal), tonic-clonic (grand mal), myoclonic, and partial seizures.

• Dual-Action Mechanism: Works by increasing brain levels of GABA (an inhibitory neurotransmitter) and stabilizing sodium channels, which helps prevent excessive and abnormal nerve firing.

• Stabilizes Bipolar Mood Swings: Proven to be effective in treating the manic episodes associated with bipolar disorder, helping to stabilize mood and prevent extreme emotional highs.

• Migraine Prevention: Clinically indicated for the prophylaxis of migraine headaches, significantly reducing the frequency and severity of attacks for chronic sufferers.

• Enhanced Tolerability: The enteric-coated, controlled-release tablet is gentler on the stomach compared to immediate-release formulas, leading to fewer gastrointestinal side effects like nausea.

Medical Disclaimer: Convules CR 200 is a prescription medication. Warning: This medicine is associated with a high risk of birth defects and developmental problems in the unborn baby if taken during pregnancy. It must not be used in women of childbearing potential unless a highly effective pregnancy prevention program is in place. Monitoring of liver function and blood counts is required during treatment. Do not stop taking this medicine suddenly, as it may trigger severe seizures.